Prostate Cancer Misdiagnosis Claims UK

Quick answer: A prostate cancer misdiagnosis claim in the UK may be possible where a GP or hospital missed clear warning signs, failed to act on a raised PSA result or an abnormal examination, or delayed referral, scans or biopsy — and that delay allowed the cancer to progress in a way that changed your treatment or outcome. The law does not treat every late diagnosis as negligence. The NHS does not offer routine PSA screening to most men, so not testing a man without symptoms is not usually negligent in itself. Claims turn on what the clinicians knew, what a competent doctor would have done, and whether acting sooner would probably have made a real difference. Most adults have three years from their date of knowledge. For a free, no-obligation review, start with the Quick Claim Form on mayiclaim.co.uk. No one can value a claim properly on first contact.

At a glance

A claim may arise where symptoms, a raised PSA or an abnormal rectal examination were not acted on, or where a result was lost, misfiled or not followed up.
NICE guideline NG12 sets age-specific PSA thresholds and says to refer on a suspected cancer pathway if the prostate feels malignant on examination.
There is no national population PSA screening programme. Men can ask their GP about a PSA test after a discussion of benefits and risks.
In 2026, a targeted screening programme for men with a BRCA2 gene variant was recommended and accepted for England, with rollout expected to begin in 2027.
Causation is usually the hardest part. Many prostate cancers grow slowly, so experts must show the delay probably changed the stage, grade, treatment options or outlook.
Usual adult time limit: three years from date of knowledge, with different rules for fatal claims and for people who lack capacity.
Start with the Quick Claim Form on mayiclaim.co.uk — free, confidential and with no obligation.

Screening, symptoms and results: where a claim may or may not arise

Prostate cancer claims depend heavily on the situation you were in when you saw the doctor. This table gives general context, not legal advice.

Your situation	What current guidance says	Could a claim arise?
No symptoms, no test discussed	No routine NHS PSA screening for most men. Targeted screening for men with a BRCA2 variant is accepted for England, with rollout expected from 2027	Usually no. Not testing a man without symptoms is generally not negligent
You asked for a PSA test	Men can ask their GP about a PSA test. The GP should discuss benefits and risks and support an informed decision	Rarely, unless a request was refused without proper discussion and that clearly caused harm. These cases are fact-specific
Urinary symptoms, erectile dysfunction or visible blood in urine	NICE NG12: consider a PSA test and rectal examination	Possibly, if symptoms were dismissed without assessment and the delay changed the outcome
PSA above the NICE age threshold	NICE NG12: consider referral on a suspected cancer pathway	Possibly, if a raised result was not acted on, repeated sensibly or explained to you
Prostate feels malignant on examination	NICE NG12: refer on a suspected cancer pathway	Possibly, if no urgent referral was made
Scan or biopsy stage	NICE NG131: MRI first, with biopsy guided by the MRI score	Possibly, if a scan or biopsy was misreported or an abnormal result was not followed up

Prostate cancer testing in the UK in 2026

Much of the confusion comes from PSA testing. PSA (prostate-specific antigen) is a protein made by the prostate. A raised level can be a sign of cancer, but it can also be caused by a benign enlarged prostate, infection or other factors. A normal result does not always rule cancer out, and a high result does not always mean cancer.

The NHS website explains that routine PSA testing is not offered on the NHS unless you have a BRCA2 gene variant. You may be offered a test if a doctor thinks your symptoms could be caused by prostate cancer. Anyone with a prostate can also ask their GP about a PSA test. The doctor should discuss the possible benefits and risks before a decision is made. Cancer Research UK’s guidance for health professionals says that where a man without symptoms asks for a test, the GP should assess risk factors such as family history, support an informed decision and record the discussion. Older guidance tools have been retired, so claims are judged against the guidance in force at the time.

On screening, the UK National Screening Committee confirmed at its March 2026 meeting a recommendation for targeted PSA screening. This would test men aged 45 to 61 with a pathogenic BRCA2 variant and a family history of breast, ovarian, pancreatic or prostate cancer every two years. The minutes were published on 28 May 2026. The committee recommended against screening the general population and against screening other groups on current evidence, including Black men and men with a family history but no BRCA2 variant. On 2 June 2026, the Secretary of State for Health and Social Care accepted the recommendation for England in a written statement, with rollout expected to begin in 2027. The other UK nations make their own decisions.

So most prostate cancer claims are not about a failure to screen. They are about what happened after symptoms were reported or a result came back.

What NICE guidance says about referral

NICE guideline NG12 (Suspected cancer: recognition and referral) is the main reference for GPs. For prostate cancer it says:

Refer on a suspected cancer pathway if the prostate feels malignant on digital rectal examination (DRE).
Consider a PSA test and DRE for men with lower urinary tract symptoms such as needing to pass urine at night, frequency, hesitancy, urgency or retention, as well as erectile dysfunction or visible blood in the urine.
Consider a suspected cancer referral if the PSA is above the threshold for the man’s age, taking into account his preferences and any other conditions. The thresholds are above 2.5 micrograms per litre for ages 40 to 49, above 3.5 for 50 to 59, above 4.5 for 60 to 69 and above 6.5 for 70 to 79. For men under 40 or over 79, NICE leaves the decision to clinical judgement.

After referral, NICE guideline NG131 (Prostate cancer: diagnosis and management) recommends a multiparametric MRI scan as the first investigation for suspected localised prostate cancer, scored on a five-point scale. A biopsy is usually offered where the score is 3 or above, while at 1 or 2 a biopsy may be omitted after a shared decision. NG131 also says a biopsy should not be offered automatically on the basis of a PSA result alone. Once cancer is found, NICE uses five Cambridge Prognostic Groups (CPG 1 to 5) to guide treatment. For the lowest-risk group, active surveillance is usually offered instead of immediate treatment.

NICE guidance is clinical context, not a legal checklist, and “consider” leaves room for judgement. But an unexplained failure to act on a malignant-feeling prostate or a clearly raised PSA is exactly what experts examine.

When is a delayed prostate cancer diagnosis negligence?

Courts in England and Wales apply the Bolam and Bolitho tests. Care is judged against what a responsible body of competent practitioners would have done, provided that view stands up to logical analysis. As explained in our guide to cancer misdiagnosis claims, four elements usually need proving:

Duty of care — present once a GP, hospital or clinic assessed or treated you.
Breach of duty — the care fell below a competent standard. Examples include a raised PSA left without action, symptoms that went unassessed, a malignant-feeling prostate not referred urgently, a misreported MRI or biopsy, or a lost result.
Causation — on the balance of probabilities, earlier competent care would have led to a better outcome. This is often the decisive issue.
Loss — measurable harm caused by the delay, such as more radical treatment, spread of the cancer, a worse prognosis, or financial losses.

Why causation is so important in prostate cancer claims

Prostate cancer varies widely. Some cancers grow so slowly they would never cause harm, and treating them can cause side effects such as incontinence or erectile problems — the problem doctors call overdiagnosis. Others are aggressive.

This matters legally. A delay in finding a low-risk cancer that is still suitable for active surveillance may have caused little or no additional harm, even if the care was poor. A delay that allowed a cancer to grow beyond the prostate, move into a higher-risk group, or spread to the bones is very different. It may have removed the chance of curative treatment or meant harsher treatment was needed. Independent urology and oncology experts compare the likely stage and grade at the earlier date with what was eventually found, then consider what treatment and outcome would probably have followed. For more on how this works across cancers, see delayed cancer diagnosis claims.

Common scenarios in prostate cancer misdiagnosis claims

Urinary symptoms put down to “age”. Repeated visits with night-time urination or a weak flow, treated as benign enlargement without a PSA test or examination being considered.
Raised PSA not acted on. A result above the age threshold filed as “normal”, not repeated when that would have been sensible, or not explained to the patient.
No referral after an abnormal examination. A hard or irregular prostate noted on DRE without urgent referral.
Results lost between services. Recommended follow-up or repeat testing is never arranged.
Misreported MRI or biopsy. A scan or sample that a competent specialist would have read differently.
Active surveillance not monitored. Planned PSA tests or scans missed, allowing progression to go unnoticed.

Many of these begin in general practice. See GP negligence claims. Similar patterns appear in our guides to bowel cancer misdiagnosis compensation and breast cancer misdiagnosis compensation.

Evidence that helps a prostate cancer claim

A specialist solicitor usually obtains the records with your written authority. Useful evidence includes:

GP records covering the full period, including consultation notes and any symptom history
All PSA results with dates, and any notes on how they were interpreted or communicated
Records of any DRE, including what was found
Referral letters and dates, and any hospital appointment letters
MRI reports and scores, biopsy reports and pathology results, including grade
Multidisciplinary team (MDT) notes and staging information
Your own timeline of symptoms and appointments, plus any complaint responses
Evidence of financial losses, such as time off work, travel and care

Compensation: what affects the value of a prostate cancer claim?

Important: No reputable adviser can value a prostate cancer claim on first contact, and May I Claim does not quote figures before the records and expert evidence are reviewed. This section explains what affects value. For broader context, see cancer misdiagnosis compensation in the UK.

Compensation covers the harm caused by the delay — not the cancer itself, which you would have had anyway. It has two parts:

General damages for pain, suffering and loss of amenity caused by the delay. This might include more invasive treatment, side effects such as incontinence or erectile dysfunction that earlier treatment would probably have avoided, spread of the cancer, a reduced life expectancy, and psychological impact.
Special damages for financial losses caused by the delay, such as lost earnings, care and assistance, travel, adaptations, and future losses.

Value depends on the difference between the likely earlier outcome and what actually happened, how treatment changed, whether the prognosis worsened, your age and work, and the evidence. If a delay contributed to a death, the family may be able to claim. See fatal hospital negligence claims.

Time limits for prostate cancer misdiagnosis claims

Most adult claims in England and Wales must be started at court within three years under the Limitation Act 1980. The three years usually run from the date of the negligence or, if later, your date of knowledge — when you first knew, or reasonably should have known, that a significant injury might be linked to the care you received. In delayed cancer cases, that is often when a specialist explains that the cancer should have been found earlier.

If the injured person lacks mental capacity to manage a claim, time usually does not run while that continues. After a death, the family generally has three years from the date of death or from their own date of knowledge. The under-18 rule, which pauses the clock until age 18, rarely applies to prostate cancer but is part of the same Act. Courts can allow late claims in limited cases, but you should not rely on that. See personal injury claim time limits in the UK and how long a medical negligence claim takes.

This article is written primarily for England and Wales. Scotland and Northern Ireland have their own rules.

NHS or private care

NHS claims are normally handled by NHS Resolution, including NHS GP care in England since April 2019 under the Clinical Negligence Scheme for General Practice. Claiming does not affect your NHS treatment. See NHS negligence claims and can I sue the NHS for a delayed cancer diagnosis?. Private clinics and consultants are usually defended by their indemnity insurers. Your solicitor follows the Pre-Action Protocol for the Resolution of Clinical Disputes before any court action.

How the May I Claim process works

May I Claim connects people with an independent panel of specialist solicitors. We do not cold-call, and we are not the acting law firm: the legal work is done by the panel solicitor matched to your case. Clinical negligence claims are usually funded on a no win, no fee Conditional Fee Agreement, with any success fee capped at 25% of damages (excluding future losses). See our no win no fee claims guide, our cancer compensation claims page and our medical negligence service.

Complete the Quick Claim Form on mayiclaim.co.uk.
Free review of what happened and whether it is worth investigating.
Specialist match with an independent panel solicitor experienced in cancer claims.
Funding explained in writing before substantive work begins.
Evidence — records, PSA and scan timelines, and independent urology or oncology reports.
Letter of Claim to NHS Resolution or the private insurer.
Negotiation or court — most claims settle without a trial. Many cancer claims take between 18 months and 3 years.

FAQs

Can I claim if my GP didn’t do a PSA test?
Usually only if you had symptoms or risk factors that should have prompted one, or a request was handled badly, and the delay changed your outcome. There is no routine PSA screening for most men, so not testing a man without symptoms is not generally negligent.

My PSA was raised but nothing happened. Do I have a claim?
Possibly. NICE sets age-specific PSA thresholds for considering a suspected cancer referral. If a clearly raised result was ignored, not repeated when appropriate, or not explained to you, and that delay made things worse, a specialist should review it.

Is prostate cancer screening available on the NHS?
Not for the general population. A targeted programme for men aged 45 to 61 with a BRCA2 variant and relevant family history has been accepted for England, with rollout expected to begin in 2027.

Can my family claim if my father died after a delayed diagnosis?
Possibly. Where a negligent delay caused or contributed to a death, the estate and eligible dependants may be able to claim within the fatal-claim time limits.

How long do I have to claim?
Usually three years from the date of negligence or your date of knowledge. Get advice early, as gathering records takes time.

Next step

If you think a prostate cancer diagnosis was missed or delayed, complete the Quick Claim Form on mayiclaim.co.uk.

Thanks — we’ll be in touch about your enquiry.

When you submit the form, you will be asked to confirm: I agree that May I Claim may contact me by phone, SMS or email about this enquiry.

We’ll only use your details to follow up on the claim you’ve asked about. You’re not signing up for cold calls or unrelated solicitor spam. You can ask us to stop anytime.

May I Claim connects you with an independent panel of specialists. We don’t sell your details for cold calling.

This article is general information about UK clinical negligence claims, not legal or medical advice for your individual circumstances. No compensation outcome is guaranteed. mayiclaim is a trading name of R Costings Limited (Registered in England No. 4804492), regulated by the Financial Conduct Authority (FCA) under FRN 836625. May I Claim connects you with an independent panel of specialist solicitors; the legal work on any claim is carried out by the panel firm matched to your case.

Prostate Cancer Misdiagnosis Claims UK: Can You Claim for a Delayed Diagnosis?